Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urethral Neoplasms × Introns × Clear all

Sponsor

Conditions

Melanoma 12 Multiple Myeloma 3 Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Leukemia-Lymphoma, Adult T-Cell 1 Leukemia 1 Hematologic Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Gemcitabine 7 Cisplatin 5 Ramucirumab 3 Platinum 3 Paclitaxel 3 Docetaxel 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 Carboplatin 2 rucaparib 1 pegfilgrastim 1 pazopanib 1 eribulin 1 enzalutamide 1 enfortumab vedotin 1 dehydroftorafur 1 avelumab 1 atezolizumab 1 aflibercept 1 Taxes 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Specimen Handling 1 Sorafenib 1 Radiotherapy 1 Radiation 1 N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1 Mitozytrex 1 Mitomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡